Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rumblings of Change in the Hearing Markets: Sonova Buys Advanced Bionics

This article was originally published in Start Up

Executive Summary

The hearing markets have followed a different evolutionary branch than the rest of the medical world, with a complicated infrastructure, and a schism between its two main product categories; the hearing aids sold through the audiology channel, and cochlear implants, surgical devices marketed to ENTs. This fragmentation has long kept the hearing markets from realizing their potential. The recent merger of Advanced Bionics with Sonova is a major step toward bridging the chasm in the hearing impairment industry, and perhaps in beginning to change its dynamics.

You may also be interested in...



New GSK Spin-Out Targets Hearing Loss

The second spin-out to emerge after GSK's 2010 exit from neurosciences-related R&D, Autifony Therapeutics may receive up to 10 million pounds in Series A funding to develop preclinical assets for hearing disorders.

Drugs for Hearing Loss: A Sound Opportunity

Hearing loss is an arena largely ignored by the biopharmaceutical industry, with most of the innovation coming from med-tech players. That situation is ripe for change as a vanguard of start-ups is attempting to develop novel therapies to treat a variety of hearing disorders, including Ménière's disease and sudden sensorineural hearing loss.

A Boom in Devices for the Hearing Impaired

Competition is spurring innovation in the hearing aid market and providers are excited at the prospect of adopting new products that can improve on existing treatments. The hottest area at the moment is implantable hearing aid devices. It's not a new concept, but it's one that many believe will command a significant share of the market.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

SC091721

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel